ketamine has been researched along with Stevens-Johnson Syndrome in 1 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawamura, A | 1 |
| Tsuboi, K | 1 |
| Oka, A | 1 |
| Sakaguchi, H | 1 |
| Suzuki, Y | 1 |
1 other study available for ketamine and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
Anesthesia management in a child with mucopolysaccharidosis and toxic epidermal necrolysis: A case report.
Topics: Anesthesia; Child; Child, Preschool; Humans; Ketamine; Male; Mucopolysaccharidosis II; Propofol; Ste | 2024 |